FT

FDA advisory panel reviews Johnson & Johnson’s Covid-19 vaccine

Decision could pave the way for authorisation of first single-dose jab in boost to vaccination campaigns

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Back to top button